These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 26431402)

  • 1. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
    Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
    PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
    Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
    Lee GC; Lawson KA; Burgess DS
    Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea.
    Kim J; Lee JY; Kim SI; Song W; Kim JS; Jung S; Yu JK; Park KG; Park YJ
    Ann Lab Med; 2014 Jan; 34(1):20-5. PubMed ID: 24422191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital.
    Zhao ZC; Xu XH; Liu MB; Wu J; Lin J; Li B
    Am J Infect Control; 2014 May; 42(5):e61-4. PubMed ID: 24773806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
    Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
    Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area.
    Cheng VC; Chan JF; Wong SC; Chen JH; Tai JW; Yan MK; Kwan GS; Tse H; To KK; Ho PL; Yuen KY
    Chin Med J (Engl); 2013 Dec; 126(23):4504-9. PubMed ID: 24286415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
    Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
    J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals.
    Ben-David D; Masarwa S; Adler A; Mishali H; Carmeli Y; Schwaber MJ
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):802-9. PubMed ID: 24915207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
    Knight GM; Dyakova E; Mookerjee S; Davies F; Brannigan ET; Otter JA; Holmes AH
    BMC Med; 2018 Aug; 16(1):141. PubMed ID: 30111322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.
    Ciobotaro P; Flaks-Manov N; Oved M; Schattner A; Hoshen M; Ben-Yosef E; Balicer RD; Zimhony O
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):188-96. PubMed ID: 26750741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal carriage of carbapenem-resistant
    Mohan B; Prasad A; Kaur H; Hallur V; Gautam N; Taneja N
    Indian J Med Microbiol; 2017; 35(4):555-562. PubMed ID: 29405149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of colonization of health care workers by carbapenem-resistant Enterobacteriaceae in an endemic hospital: A prospective study.
    Bitterman R; Geffen Y; Rabino G; Eluk O; Warman S; Greenblatt AS; Neuberger A; Reisner SA; Hussein K; Paul M
    Am J Infect Control; 2016 Sep; 44(9):1053-4. PubMed ID: 27125914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors and Outcomes for Intestinal Carriage of AmpC-Hyperproducing Enterobacteriaceae in Intensive Care Unit Patients.
    Poignant S; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1883-7. PubMed ID: 26666938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.
    Reuben J; Donegan N; Wortmann G; DeBiasi R; Song X; Kumar P; McFadden M; Clagon S; Mirdamadi J; White D; Harris JE; Browne A; Hooker J; Yochelson M; Walker M; Little G; Jernigan G; Hansen K; Dockery B; Sinatro B; Blaylock M; Harmon K; Iyengar P; Wagner T; Nelson JA;
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):921-929. PubMed ID: 28615088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
    Goodman KE; Simner PJ; Tamma PD; Milstone AM
    Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study.
    Bart Y; Paul M; Eluk O; Geffen Y; Rabino G; Hussein K
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):936-41. PubMed ID: 25869912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.